Papers
9
Total Citations
302
H-Index
8
About
Roberto Bertini is a leading urologic oncologist whose research has fundamentally advanced the surgical management of kidney and prostate cancers. His primary contributions center on optimizing perioperative outcomes and developing predictive tools for patients undergoing partial nephrectomy. As a principal investigator in the landmark RECORd 2 Project, Bertini led a prospective multicenter observational study involving over 4,300 patients, comparing open, laparoscopic, and robotic approaches. This work, cited over 130 times, provided critical evidence on the safety and efficacy of minimally invasive techniques for renal tumors. He further specialized in complex cases, demonstrating that even high-complexity (PADUA score ≥10) tumors can be managed effectively with partial nephrectomy. Bertini’s impact is amplified by his development of clinically-validated nomograms that predict postoperative complications and intermediate renal function loss, tools now used by surgeons worldwide for preoperative counseling. His research also extends to prostate cancer, where he documented stage migration following the introduction of robotic training programs. With a career spanning over two decades and publications exceeding 250 citations, Bertini remains a pivotal figure in evidence-based urologic surgery, shaping how clinicians balance oncologic control with functional preservation.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9